trial
as of 2026-07-01Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)
NCTId NCT00934466
at a glance
Phase 1 · Completed
Enrollment 15 (actual)
Sponsored by Merck Sharp & Dohme LLC
Primary completion 2009-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
15 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2009-07
Primary completion
2009-12
Eligibility
MALE · 18 Years · 40 Years
Interventions & indications
Sponsors
Merck Sharp & Dohme LLCLead Sponsor
Sites
0 total
Facts & assertions
4 sourced
Enrollment
15
Phase
PHASE1
Primary Completion Date
2009-12
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
indication
indication
indication